John Ridley

532 total citations
14 papers, 450 citations indexed

About

John Ridley is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, John Ridley has authored 14 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Cardiology and Cardiovascular Medicine and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in John Ridley's work include Ion channel regulation and function (13 papers), Cardiac electrophysiology and arrhythmias (11 papers) and Receptor Mechanisms and Signaling (4 papers). John Ridley is often cited by papers focused on Ion channel regulation and function (13 papers), Cardiac electrophysiology and arrhythmias (11 papers) and Receptor Mechanisms and Signaling (4 papers). John Ridley collaborates with scholars based in United Kingdom and Italy. John Ridley's co-authors include Harry J. Witchel, Jules C. Hancox, James T. Milnes, Rona S. Duncan, Christopher E. Dempsey, Mark J. McPate, Annarosa Arcangeli, Andrew F. James, Joanne L. Leaney and Olivia Crociani and has published in prestigious journals such as The Journal of Physiology, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

John Ridley

13 papers receiving 426 citations

Peers

John Ridley
Jane A. Bursill Australia
J‐P Valentin United Kingdom
William Reynolds United States
Mark J. McPate United Kingdom
Serguei S. Sidach United States
Bronagh Heath United Kingdom
Rona S. Duncan United Kingdom
Chieko Kasai Japan
MA Vos Netherlands
Walter A. Volberg United States
Jane A. Bursill Australia
John Ridley
Citations per year, relative to John Ridley John Ridley (= 1×) peers Jane A. Bursill

Countries citing papers authored by John Ridley

Since Specialization
Citations

This map shows the geographic impact of John Ridley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Ridley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Ridley more than expected).

Fields of papers citing papers by John Ridley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Ridley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Ridley. The network helps show where John Ridley may publish in the future.

Co-authorship network of co-authors of John Ridley

This figure shows the co-authorship network connecting the top 25 collaborators of John Ridley. A scholar is included among the top collaborators of John Ridley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Ridley. John Ridley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Ridley, John, et al.. (2022). Development of ASIC1a ligand-gated ion channel drug screening assays across multiple automated patch clamp platforms. Frontiers in Molecular Neuroscience. 15. 982689–982689. 3 indexed citations
2.
Rogers, Marc, et al.. (2021). Validation of an ASIC1a Ligand-Gated Assay on an Automated Patch Clamp Platform and its Use for Novel Ligand Screening. Biophysical Journal. 120(3). 337a–337a. 1 indexed citations
3.
Warren, Madhuri, et al.. (2011). Analysis of Protein Biomarkers in Human Clinical Tumor Samples: Critical Aspects to Success from Tissue Acquisition to Analysis. Biomarkers in Medicine. 5(2). 227–248. 4 indexed citations
4.
Ridley, John, et al.. (2008). Spontaneous frequency of rabbit atrioventricular node myocytes depends on SR function. Cell Calcium. 44(6). 580–591. 17 indexed citations
5.
Duncan, Rona S., Mark J. McPate, John Ridley, et al.. (2007). Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin. Biochemical Pharmacology. 74(3). 425–437. 44 indexed citations
6.
Ridley, John, James T. Milnes, Rona S. Duncan, et al.. (2006). Inhibition of the HERG K+channel by the antifungal drug ketoconazole depends on channel gating and involves the S6 residue F656. FEBS Letters. 580(8). 1999–2005. 29 indexed citations
7.
Duncan, Rona S., John Ridley, Christopher E. Dempsey, et al.. (2006). Erythromycin block of the HERG K+ channel: Accessibility to F656 and Y652. Biochemical and Biophysical Research Communications. 341(2). 500–506. 32 indexed citations
8.
Ridley, John, James T. Milnes, Jules C. Hancox, & Harry J. Witchel. (2005). Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channel. Journal of Molecular and Cellular Cardiology. 40(1). 107–118. 41 indexed citations
9.
Ridley, John, James T. Milnes, Harry J. Witchel, & Jules C. Hancox. (2004). High affinity HERG K+ channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656. Biochemical and Biophysical Research Communications. 325(3). 883–891. 69 indexed citations
10.
Yuill, Kathryn H., John J. Borg, John Ridley, et al.. (2004). Potent inhibition of human cardiac potassium (HERG) channels by the anti-estrogen agent clomiphene—without QT interval prolongation. Biochemical and Biophysical Research Communications. 318(2). 556–561. 22 indexed citations
11.
Ridley, John. (2004). Lidoflazine is a high affinity blocker of the HERG K+channel. Journal of Molecular and Cellular Cardiology. 36(5). 701–705. 49 indexed citations
12.
Ridley, John, et al.. (2003). Characterisation of recombinant HERG K+ channel blockade by the Class Ia antiarrhythmic drug procainamide. Biochemical and Biophysical Research Communications. 306(2). 388–393. 27 indexed citations
13.
Ridley, John, et al.. (2003). Inhibition of HERG K+ Current and Prolongation of the Guinea‐Pig Ventricular Action Potential by 4‐Aminopyridine. The Journal of Physiology. 549(3). 667–672. 50 indexed citations
14.
Milnes, James T., Christopher E. Dempsey, John Ridley, et al.. (2003). Preferential closed channel blockade of HERG potassium currents by chemically synthesised BeKm‐1 scorpion toxin. FEBS Letters. 547(1-3). 20–26. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jane A. Bursill Breakdown of academic impact, for papers by J‐P Valentin Breakdown of academic impact, for papers by William Reynolds Breakdown of academic impact, for papers by Mark J. McPate Breakdown of academic impact, for papers by Serguei S. Sidach Breakdown of academic impact, for papers by Bronagh Heath Breakdown of academic impact, for papers by Rona S. Duncan Breakdown of academic impact, for papers by Chieko Kasai Breakdown of academic impact, for papers by MA Vos Breakdown of academic impact, for papers by Walter A. Volberg
Rankless by CCL
2026